Aldeyra Therapeutics, Inc. (ALDX) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$4.75
Day's range
$5.3

Aldeyra Therapeutics Inc Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
KNOLL CAPITAL MANAGEMENT, LLC 09/10/2026 5.48 M $11.66 M   0.00% 9.08%
AQR CAPITAL MANAGEMENT LLC 08/14/2026 3.75 M $7.99 M   32.57% 6.22%
KINGDON CAPITAL MANAGEMENT, L.L.C. 08/14/2026 2.65 M $5.65 M   23.23% 4.40%
VANGUARD CAPITAL MANAGEMENT LLC 08/13/2026 2.36 M $5.03 M   -0.08% 3.92%
D. E. SHAW & CO., INC. 08/14/2026 1.94 M $4.13 M   38.20% 3.22%
MARSHALL WACE, LLP 08/13/2026 1.51 M $3.21 M   1,061.95% 2.50%
683 CAPITAL MANAGEMENT, LLC 08/14/2026 1.45 M $3.09 M   -3.33% 2.40%
JANE STREET GROUP, LLC 08/14/2026 1.38 M $2.93 M   41.93% 2.28%
BLACKROCK, INC. 08/07/2026 1.26 M $2.68 M   -66.60% 2.08%
QUBE RESEARCH & TECHNOLOGIES LTD 08/14/2026 1.13 M $2.40 M   1,196.31% 1.87%
ACADIAN ASSET MANAGEMENT LLC 08/13/2026 1.06 M $2.26 M   23.94% 1.76%
ARDSLEY ADVISORY PARTNERS LP 07/13/2026 975.00 K $2.08 M   2.63% 1.62%
RENAISSANCE TECHNOLOGIES LLC 08/13/2026 882.00 K $1.88 M   2.18% 1.46%
VANGUARD PORTFOLIO MANAGEMENT LLC 08/13/2026 794.86 K $1.69 M   -1.60% 1.32%
GOLDMAN SACHS GROUP INC 08/14/2026 725.44 K $1.55 M   33.56% 1.20%
JACOBS LEVY EQUITY MANAGEMENT, INC 08/14/2026 646.84 K $1.38 M   -18.82% 1.07%
MORGAN STANLEY 08/13/2026 608.32 K $1.30 M   17.29% 1.01%
GEODE CAPITAL MANAGEMENT, LLC 08/12/2026 596.03 K $1.27 M   -52.38% 0.99%
DIMENSIONAL FUND ADVISORS LP 08/11/2026 529.08 K $1.13 M   -15.23% 0.88%
GSA CAPITAL PARTNERS LLP 08/06/2026 472.56 K $1.01 M   91.17% 0.78%
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP 08/13/2026 421.18 K $897.11 K   100.00% 0.70%
CITADEL ADVISORS LLC 09/02/2026 379.14 K $807.58 K   42.35% 0.63%
MILLENNIUM MANAGEMENT LLC 08/14/2026 360.35 K $767.55 K   -63.79% 0.60%
UBS GROUP AG 08/13/2026 301.94 K $643.13 K   -43.83% 0.50%
ARDSLEY ADVISORY PARTNERS LP 07/13/2026 300.00 K $639.00 K   0.00% 0.50%
VANGUARD FIDUCIARY TRUST CO 08/13/2026 298.24 K $635.26 K   -11.92% 0.49%
XTX TOPCO LTD 08/14/2026 254.78 K $542.68 K   238.95% 0.42%
WOODSTOCK CORP 07/13/2026 242.76 K $517.07 K   -9.00% 0.40%
STATE STREET CORP 09/22/2026 233.77 K $497.94 K   -79.21% 0.39%
IEQ CAPITAL, LLC 08/11/2026 206.59 K $440.04 K   -22.48% 0.34%
CANTOR FITZGERALD, L. P. 08/19/2026 200.00 K $426.00 K   100.00% 0.33%
CAPTION MANAGEMENT, LLC 08/14/2026 165.00 K $351.45 K   0.00% 0.27%
CITADEL ADVISORS LLC 09/02/2026 163.60 K $348.47 K   32.04% 0.27%
WELLS FARGO & COMPANY/MN 08/14/2026 162.34 K $345.78 K   -14.44% 0.27%
INVESCO LTD. 08/14/2026 159.54 K $339.82 K   -5.99% 0.26%
BNP PARIBAS ARBITRAGE, SNC 08/13/2026 157.25 K $334.94 K   427.41% 0.26%
PALO ALTO INVESTORS LP 08/19/2026 155.71 K $331.66 K   0.00% 0.26%
POINT72 ASSET MANAGEMENT, L.P. 08/14/2026 154.41 K $328.89 K   100.00% 0.26%
CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. 08/13/2026 154.29 K $328.64 K   100.00% 0.26%
MAN GROUP PLC 08/14/2026 152.71 K $325.28 K   100.00% 0.25%
JAIN GLOBAL LLC 08/14/2026 131.50 K $280.10 K   100.00% 0.22%
TWO SIGMA INVESTMENTS, LP 08/14/2026 127.85 K $272.32 K   -42.81% 0.21%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 08/14/2026 117.60 K $250.49 K   7.01% 0.20%
JPMORGAN CHASE & CO 08/12/2026 109.58 K $224.64 K   373.18% 0.18%
NORTHERN TRUST CORP 08/13/2026 108.89 K $231.93 K   -70.95% 0.18%
KENNEDY CAPITAL MANAGEMENT LLC 08/14/2026 97.73 K $208.16 K   1.94% 0.16%
CANADA PENSION PLAN INVESTMENT BOARD 08/14/2026 94.30 K $200.86 K   98.95% 0.16%
SQUAREPOINT OPS LLC 08/14/2026 94.05 K $200.32 K   100.00% 0.16%
RUSSELL INVESTMENTS GROUP, LTD. 08/06/2026 90.35 K $192.45 K   7.18% 0.15%
MARINER, LLC 08/13/2026 90.34 K $192.37 K   -1.67% 0.15%

Aldeyra Therapeutics Inc institutional Ownership - FAQ's

During the previous two years, 180 institutional investors and hedge funds held shares of Aldeyra Therapeutics Inc. The most heavily invested institutionals were:

Knoll Capital Management, LLC: 5.48 M

AQR CAPITAL MANAGEMENT LLC: 3.75 M

KINGDON CAPITAL MANAGEMENT, L.L.C.: 2.65 M

VANGUARD CAPITAL MANAGEMENT LLC: 2.36 M

D. E. Shaw & Co., Inc.: 1.94 M

MARSHALL WACE, LLP: 1.51 M

60.56% of Aldeyra Therapeutics Inc stock is owned by institutional investors.

Institutional investors have bought a total of 45.86 M shares in the last 24 months. This purchase volume represents approximately $241.24 M in transactions.